• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • All Features
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Diary
    • NEWS
    • Reports
    Pharmaceuticals & Biotech.
    Sector
    Watch
    Load latest
    P
    Pharmaceuticals & Biotech.
    SECTOR | 07 Oct 2024
    Here's why Natco Pharma share price gained over 4% on October 7; details
    Business Standard
    Natco Pharma share rose after the company announced that Mylan Pharmaceuticals Inc & Novo Nordisk have reached a settlement of the US patent litigation related to generic Ozempic (Semaglutide)
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 03 Oct 2024, 08:27PM
    Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
    Business Line
    Patent opposition case at Indian Patent Office comes up later this month
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 03 Oct 2024, 04:17PM
    India Joins As Affiliate Member Of Global Medical Device Regulators Forum
    India Joins As Affiliate Member Of Global Medical Device Regulators Forum
    NDTV Profit
    Becoming an affiliate member of the IMDRF will open doors to collaboration with regulatory authorities worldwide.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 02 Oct 2024
    Dr Reddy's Hetero ties up with Gilead Sciencesfor anti-HIV drug Lenacapavir
    Business Line
    The tie up will enable the company to distribute the drug to 120 countries with low and lower-middle income
    Copy LinkShare onShare on Share on Share on
    Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
    Business Standard | 02 Oct 2024
    P
    Pharmaceuticals & Biotech.
    SECTOR | 01 Oct 2024
    Centre Mulls Tweaking Regulatory Norms For MedTech And Pharma Sectors
    Centre Mulls Tweaking Regulatory Norms For MedTech And Pharma Sectors
    NDTV Profit
    As per the government's stated vision of making India a developed country by 2047, there is a need to enhance exports from India, Niti Aayog member (Health) VK Paul said.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 30 Sep 2024
    Marburg virus outbreak: What is this infection? Should India be concerned?
    Business Standard
    Like Ebola, the Marburg virus is also a contagious illness. At least six people have passed away in Rwanda's first-ever outbreak of the deadly Marburg virus. The virus was first identified in 1967
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 26 Sep 2024
    Biocon Partners With Tabuk Pharma To Commercialise Its Diabetes Treatment Drug
    Biocon Partners With Tabuk Pharma To Commercialise Its Diabetes Treatment Drug
    NDTV Profit
    Under the agreement, Biocon will produce and develop the products while Tabuk Pharmaceuticals will market, register, import, and promote them in the Middle East.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 26 Sep 2024
    Stocks To Watch: Pharma Companies, Five-Star Business, ASK Automotive, ONGC, IDFC
    Stocks To Watch: Pharma Companies, Five-Star Business, ASK Automotive, ONGC, IDFC
    NDTV Profit
    Investors will keep their focus on pharma companies, along with shares of Five-Star Business, ASK Automotive, ONGC and IDFC during the trade session Thursday.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 19 Sep 2024
    Pharma companies eyeing acquisitions in API and formulation space to consolidate market share: CRISIL
    Pharma companies eyeing acquisitions in API and formulation space to consolidate market share: CRISIL
    Business Today
    The Indian pharmaceutical sector is expected to maintain its growth, driven by a strategy focused on increasing market share and diversifying product offerings. The sector is projected to see revenue growth of 8-10 percent this fiscal year, building on last year's 10 percent growth, CRISIL said.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 17 Sep 2024
    Patent opposition case against Gilead's long-acting HIV injectable drug, comes up this week
    Business Line
    The drug priced at over $40,000, per person, per year, poses a challenge
    Copy LinkShare onShare on Share on Share on
    Indian Patent Office to hear objections on Gilead's HIV drug patent claims
    Business Standard | 17 Sep 2024
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    • All Features
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2026 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)